{"@context":"https://schema.org","@type":"Corporation","name":"GLAXOSMITHKLINE PHARMA LT","alternateName":"GLAXO","tickerSymbol":"GLAXO","identifier":"GLAXO","description":"GLAXOSMITHKLINE PHARMA LT (GLAXO) financials: Market Cap ₹41,748Cr., Price ₹2,464, P/E 39.4, ROE 43.3%. Jun 2026: sales ₹924 Cr, net profit ₹253 Cr. Quarterly…","url":"https://fincrux.org/companies/GLAXO","sameAs":["https://fincrux.org/companies/GLAXO"],"dateModified":"2026-10-22T05:26:44.976840","additionalProperty":[{"@type":"PropertyValue","name":"Market Cap","value":"₹41,748Cr."},{"@type":"PropertyValue","name":"Current Price","value":"₹2,464"},{"@type":"PropertyValue","name":"Stock P/E","value":"39.4"},{"@type":"PropertyValue","name":"ROE","value":"43.3%"},{"@type":"PropertyValue","name":"ROCE","value":"61.3%"},{"@type":"PropertyValue","name":"Book Value","value":"₹132"},{"@type":"PropertyValue","name":"Dividend Yield","value":"2.31%"},{"@type":"PropertyValue","name":"52W High / Low","value":"₹3,121/2,088"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://fincrux.org/companies/GLAXO#webpage","name":"GLAXOSMITHKLINE PHARMA LT (GLAXO) Financials, Quarterly Results & Ratios","url":"https://fincrux.org/companies/GLAXO","isPartOf":{"@id":"https://fincrux.org/#website"}},"publisher":{"@type":"Organization","name":"Fincrux","url":"https://fincrux.org"},"potentialAction":{"@type":"ViewAction","target":"https://fincrux.org/companies/GLAXO"}}